0001655808-24-000001.txt : 20241105 0001655808-24-000001.hdr.sgml : 20241105 20241105152037 ACCESSION NUMBER: 0001655808-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20241105 DATE AS OF CHANGE: 20241105 EFFECTIVENESS DATE: 20241105 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SeqOnce BioSciences, Inc. CENTRAL INDEX KEY: 0001655808 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-528695 FILM NUMBER: 241427178 BUSINESS ADDRESS: STREET 1: 2265 E. FOOTHILL BOULEVARD CITY: PASADENA STATE: CA ZIP: 91107 BUSINESS PHONE: 626-765-3894 MAIL ADDRESS: STREET 1: 2265 E. FOOTHILL BOULEVARD CITY: PASADENA STATE: CA ZIP: 91107 D 1 primary_doc.xml X0708 D LIVE 0001655808 SeqOnce BioSciences, Inc. 2265 E. FOOTHILL BOULEVARD PASADENA CA CALIFORNIA 91107 626-765-3894 DELAWARE SeqOnce BioSciences, LLC None Corporation true Christopher Angermayer c/o SeqOnce BioSciences, Inc. 2265 E. Foothill Blvd Pasadena CA CALIFORNIA 91107 Executive Officer Director Joseph Dunham c/o SeqOnce BioSciences, Inc. 2265 E. Foothill Blvd Pasadena CA CALIFORNIA 91107 Director Biotechnology Decline to Disclose 06b false 2024-10-14 false true true false 0 881831 881831 0 $626,481 of the total amount is in conversion of notes. false 4 0 0 0 false SeqOnce BioSciences, Inc. /s/ Christopher Angermayer Christopher Angermayer Chief Executive Officer 2024-11-05